{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:54Z","timestamp":1778619534439,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T00:00:00Z","timestamp":1179014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/nm1585","type":"journal-article","created":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T17:17:42Z","timestamp":1179076662000},"page":"711-718","source":"Crossref","is-referenced-by-count":677,"title":["TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1"],"prefix":"10.1038","volume":"13","author":[{"given":"Ahjoku","family":"Amadi-Obi","sequence":"first","affiliation":[]},{"given":"Cheng-Rong","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Xuebin","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Rashid M","family":"Mahdi","sequence":"additional","affiliation":[]},{"given":"Grace Levy","family":"Clarke","sequence":"additional","affiliation":[]},{"given":"Robert B","family":"Nussenblatt","sequence":"additional","affiliation":[]},{"given":"Igal","family":"Gery","sequence":"additional","affiliation":[]},{"given":"Yun Sang","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Charles E","family":"Egwuagu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,13]]},"reference":[{"key":"BFnm1585_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16, 779\u2013790 (2002).","journal-title":"Immunity"},{"key":"BFnm1585_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nri1648","volume":"5","author":"CA Hunter","year":"2005","unstructured":"Hunter, C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521\u2013531 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1585_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G., Pflanz, S. & Kastelein, R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641\u2013644 (2003).","journal-title":"Immunity"},{"key":"BFnm1585_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133\u2013146 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1585_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744\u2013748 (2003).","journal-title":"Nature"},{"key":"BFnm1585_CR6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1172\/JCI21404","volume":"116","author":"D Yen","year":"2006","unstructured":"Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310\u20131316 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnm1585_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ni0606-557","volume":"7","author":"DJ Cua","year":"2006","unstructured":"Cua, D.J. & Kastelein, R.A. TGF-\u03b2, a 'double agent' in the immune pathology war. Nat. Immunol. 7, 557\u2013559 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnm1585_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677\u2013688 (2006).","journal-title":"Immunity"},{"key":"BFnm1585_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/08830180212067","volume":"21","author":"RB Nussenblatt","year":"2002","unstructured":"Nussenblatt, R.B. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int. Rev. Immunol. 21, 273\u2013289 (2002).","journal-title":"Int. Rev. Immunol."},{"key":"BFnm1585_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs, D.A. et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol. 130, 492\u2013513 (2000).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnm1585_CR11","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1073\/pnas.96.13.7462","volume":"22","author":"RB Nussenblatt","year":"1999","unstructured":"Nussenblatt, R.B. et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I\/II clinical trial. Proc. Natl. Acad. Sci. USA 22, 7462\u20137466 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1585_CR12","first-page":"2563","volume":"42","author":"MD Becker","year":"2001","unstructured":"Becker, M.D., Garman, K., Whitcup, S.M., Planck, S.R. & Rosenbaum, J.T. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 42, 2563\u20132566 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnm1585_CR13","first-page":"3131","volume":"32","author":"RB Nussenblatt","year":"1991","unstructured":"Nussenblatt, R.B. Proctor lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 32, 3131\u20133141 (1991).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnm1585_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1189\/jlb.0305130","volume":"79","author":"IJ Crane","year":"2006","unstructured":"Crane, I.J. et al. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J. Leukoc. Biol. 79, 435\u2013443 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm1585_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.161.1.122","volume":"161","author":"TK Tarrant","year":"1998","unstructured":"Tarrant, T.K., Silver, P.B., Chan, C.C., Wiggert, B. & Caspi, R.R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161, 122\u2013127 (1998).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1084\/jem.189.2.219","volume":"189","author":"TK Tarrant","year":"1999","unstructured":"Tarrant, T.K. et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 189, 219\u2013230 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm1585_CR17","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.157.6.2668","volume":"157","author":"RR Caspi","year":"1996","unstructured":"Caspi, R.R. et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J. Immunol. 157, 2668\u20132675 (1996).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR18","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.4049\/jimmunol.176.9.5652","volume":"176","author":"ML Cho","year":"2006","unstructured":"Cho, M.L. et al. STAT3 and NF-\u03baB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652\u20135661 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","volume":"177","author":"Y Komiyama","year":"2006","unstructured":"Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566\u2013573 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR20","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","volume":"171","author":"S Nakae","year":"2003","unstructured":"Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173\u20136177 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR21","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1073\/pnas.1035999100","volume":"100","author":"S Nakae","year":"2003","unstructured":"Nakae, S. et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100, 5986\u20135990 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1585_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4049\/jimmunol.173.2.737","volume":"173","author":"CR Yu","year":"2004","unstructured":"Yu, C.R. et al. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173, 737\u2013746 (2004).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR23","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.4049\/jimmunol.168.7.3181","volume":"168","author":"CE Egwuagu","year":"2002","unstructured":"Egwuagu, C.E. et al. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168, 3181\u20133187 (2002).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ni1376","volume":"7","author":"JS Stumhofer","year":"2006","unstructured":"Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937\u2013945 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnm1585_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jneuroim.2005.07.021","volume":"168","author":"H Takase","year":"2005","unstructured":"Takase, H. et al. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 168, 118\u2013127 (2005).","journal-title":"J. Neuroimmunol."},{"key":"BFnm1585_CR26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","volume":"140","author":"RR Caspi","year":"1988","unstructured":"Caspi, R.R. et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490\u20131495 (1988).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver, C.T., Hatton, R.D., Mangan, P.R. & Harrington, L.E. IL-17 Family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821\u2013852 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm1585_CR28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.4049\/jimmunol.175.4.2191","volume":"175","author":"T Owaki","year":"2005","unstructured":"Owaki, T. et al. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 175, 2191\u20132200 (2005).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4049\/jimmunol.176.1.237","volume":"176","author":"AV Villarino","year":"2006","unstructured":"Villarino, A.V. et al. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176, 237\u2013247 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","volume":"7","author":"M Batten","year":"2006","unstructured":"Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929\u2013936 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnm1585_CR31","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.4049\/jimmunol.177.8.5377","volume":"177","author":"T Yoshimura","year":"2006","unstructured":"Yoshimura, T. et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177, 5377\u20135385 (2006).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR32","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic, D.V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-\u03b2 and TNF-\u03b1, by human macrophages. J. Immunol. 160, 3513\u20133521 (1998).","journal-title":"J. Immunol."},{"key":"BFnm1585_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","volume":"202","author":"WT Watford","year":"2004","unstructured":"Watford, W.T. et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202, 139\u2013156 (2004).","journal-title":"Immunol. Rev."},{"key":"BFnm1585_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/ar1227","volume":"6","author":"AV Villarino","year":"2004","unstructured":"Villarino, A.V. & Hunter, C.A. Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res. Ther. 6, 225\u2013233 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"BFnm1585_CR35","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103, 8137\u20138142 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1585_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.20060522","volume":"203","author":"CM Tato","year":"2006","unstructured":"Tato, C.M., Laurence, A. & O'Shea, J.J. Helper T cell differentiation enters a new era: le roi est mort; vive le roi!. J. Exp. Med. 203, 809\u2013812 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnm1585_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2004.12.013","volume":"232","author":"J Li","year":"2005","unstructured":"Li, J., Gran, B., Zhang, G.X., Rostami, A. & Kamoun, M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J. Neurol. Sci. 232, 3\u20139 (2005).","journal-title":"J. Neurol. Sci."},{"key":"BFnm1585_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.brainres.2005.01.100","volume":"1040","author":"Y Sonobe","year":"2005","unstructured":"Sonobe, Y. et al. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 1040, 202\u2013207 (2005).","journal-title":"Brain Res."},{"key":"BFnm1585_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui, K. et al. Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand. J. Rheumatol. 31, 205\u2013210 (2002).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnm1585_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli, G., Yentur, S.P., Akman-Demir, G., Isik, N. & Serdaroglu, P. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J. Neuroimmunol. 145, 127\u2013134 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnm1585_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","volume":"50","author":"N Okhravi","year":"2005","unstructured":"Okhravi, N., Odufuwa, B., McCluskey, P. & Lightman, S. Scleritis. Surv. Ophthalmol. 50, 351\u2013363 (2005).","journal-title":"Surv. Ophthalmol."},{"key":"BFnm1585_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00347-003-0927-7","volume":"101","author":"CM Deuter","year":"2004","unstructured":"Deuter, C.M., Kotter, I., Gunaydin, I., Zierhut, M. & Stubiger, N. Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a. Ophthalmologe 101, 129\u2013134 (2004).","journal-title":"Ophthalmologe"},{"key":"BFnm1585_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/ard.62.5.492","volume":"62","author":"M Calguneri","year":"2003","unstructured":"Calguneri, M. et al. Effects of interferon alpha treatment on the clinical course of refractory Behcet's disease: an open study. Ann. Rheum. Dis. 62, 492\u2013493 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnm1585_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0896-8411(03)00113-6","volume":"21","author":"RB Nussenblatt","year":"2003","unstructured":"Nussenblatt, R.B. et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J. Autoimmun. 21, 283\u2013293 (2003).","journal-title":"J. Autoimmun."},{"key":"BFnm1585_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2004.11.006","volume":"24","author":"CE Egwuagu","year":"2005","unstructured":"Egwuagu, C.E., Yu, C.R., Li, Z. & Nussenblatt, R.B. SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy. J. Autoimmun. 24, 39\u201346 (2005).","journal-title":"J. Autoimmun."},{"key":"BFnm1585_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000083442","volume-title":"New Methods for Culturing Cells from Nervous Tissues\u2014Bio Valley Monogr","author":"H Hofmann","year":"2005","unstructured":"Hofmann, H., Schulz-key, S., Hertle, D. & Kirsch, M. Orgaotypic cultures of the rat retina. in New Methods for Culturing Cells from Nervous Tissues\u2014Bio Valley Monogr. Vol. 1 (eds. Poindron, P., Piguet, P. & Forster, E.) 58\u201373 (Karger, Basel, Switzerland, 2005)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1585","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:29:02Z","timestamp":1684448942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,13]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BFnm1585"],"URL":"https:\/\/doi.org\/10.1038\/nm1585","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,13]]}}}